Several prediction models, including PREMM5, MMRpro, and MMRpredict, have been developed to estimate the likelihood of carrying a GPV in MMR genes, based on personal and family cancer history (Table 1) [83,84,85]. This evidence concerns the gene MRC1 and cancer.